SureTrader SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Enanta Pharmaceuticals (ENTA)

ENTA RSS Feed
Add ENTA Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator DewDiligence
Search This Board:
Last Post: 8/25/2015 6:29:18 PM - Followers: 64 - Board type: Free - Posts Today: 0
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ENTA
Current Price
Volume:
Bid Ask Day's Range
Wiki
PostSubject
#1054  Sticky Note V-Pak 2Q15 sales were $385M, +67% vs 1Q15 DewDiligence 07/24/15 12:11:33 PM
#1084   Medicaid should be treating more HCV patients, say DewDiligence 08/25/15 06:29:18 PM
#1083   I want to reformat my post and add willyw 08/22/15 10:06:13 PM
#1082   Thise #s tweeted are from IMS and the pollyvonwog 08/21/15 11:33:42 AM
#1081   Your post http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116356199 put up showed numb willyw 08/21/15 11:11:00 AM
#1080   tweeted today: biotech_researcher 08/21/15 10:47:59 AM
#1079   tweeted today willyw 08/21/15 10:25:40 AM
#1078   $GILD $ABBV $ENTA Post Launch: willyw 08/20/15 12:29:45 PM
#1077   $GILD $ABBV $ENTA Post Launch: biotech_researcher 08/20/15 07:52:35 AM
#1075   ABBV pays record $350M for priority-review voucher: DewDiligence 08/19/15 09:23:36 AM
#1074   V-Pak Rx #s.. Haven't seen these posted in pollyvonwog 08/11/15 02:32:18 PM
#1073   thanks, i could not heard the last CC lgonber 08/11/15 01:35:22 PM
#1072   Unless the option liquidity improves WorstLuck 08/11/15 11:16:31 AM
#1071   Are you still positive with ENTA?Of course; nothing DewDiligence 08/11/15 10:19:39 AM
#1070   Again could not held the $50s and back lgonber 08/11/15 10:15:03 AM
#1069   The FY3Q15 10-Q has been filed: DewDiligence 08/10/15 04:34:50 PM
#1068   I see some folks got out today. willyw 08/07/15 03:43:33 PM
#1067   And we are having another of those days. willyw 08/07/15 09:55:58 AM
#1066   Enanta Pharmaceuticals' (ENTA) CEO Jay Luly on Q2 willyw 08/07/15 09:08:32 AM
#1065   ESRX continues V-Pak exclusivity for 2016: #msg-115850576. DewDiligence 07/31/15 01:14:15 PM
#1064   Often times, I think many people investing in willyw 07/31/15 11:36:05 AM
#1063   Does anyone have a guess why ENTA DewDiligence 07/31/15 11:14:05 AM
#1062   Does anyone have a guess why ENTA has postmeridiem 07/31/15 10:59:47 AM
#1061   This makes sense to me, particularly since; willyw 07/30/15 06:14:24 PM
#1060   No particular significance, IMO. The old policy of DewDiligence 07/30/15 05:56:30 PM
#1059   A while ago you wrote; willyw 07/30/15 05:40:10 PM
#1058   FY3Q15 earnings 8/6/15—CC 4:30pm ET: DewDiligence 07/30/15 04:38:10 PM
#1057   FWIW, ENTA will be added to the S&P biotech_researcher 07/25/15 05:41:58 AM
#1056   FDA approves ABBV/ENTA’s 2-DAA regimen for GT4: #msg-115667263. DewDiligence 07/24/15 12:45:45 PM
#1055   Update from ABBV’s 2Q15 CC on next-gen HCV DewDiligence 07/24/15 12:13:05 PM
#1054   V-Pak 2Q15 sales were $385M, +67% vs 1Q15 DewDiligence 07/24/15 12:11:33 PM
#1052   Still holding long term shares presumably for WorstLuck 07/19/15 08:17:04 PM
#1051   GILD’s cutback on patient-assistance program—>somewhat bullish for ENTA: DewDiligence 07/16/15 02:57:43 PM
#1050   $500K of cumulative sales yesterday by CFO/CSO under DewDiligence 07/14/15 04:57:52 PM
#1049   Shorts covering? chantillylive 07/14/15 11:35:15 AM
#1048   All BIOS in my portafolio are up big. lgonber 07/14/15 11:27:27 AM
#1047   Highest price since 1/22/15 (before ABBV's 4Q14 results). DewDiligence 07/14/15 11:19:11 AM
#1046   Incredible action in ENTA as of late. biotech_researcher 07/14/15 11:15:20 AM
#1045   ABBV's 2Q15 CC on Jul 24 is definite—they DewDiligence 07/07/15 09:00:26 PM
#1044   I had wondered about this and then when willyw 07/07/15 08:54:05 PM
#1043   It was presumably a slip of the tongue. DewDiligence 07/07/15 03:15:10 PM
#1042   Enta showing some relative strength on a down willyw 07/07/15 03:04:47 PM
#1041   Clarification re ENTA’s $30M milestone from ABBV for DewDiligence 07/07/15 12:21:53 PM
#1040   Yes, ABBV's guidance for a greater than $3B DewDiligence 07/06/15 12:30:32 PM
#1039   If I have the info right, Gilead submitted willyw 07/06/15 12:25:57 PM
#1038   Japan approves 12-week Harvoni regimen for GT1 patients: #msg-115173303. DewDiligence 07/06/15 05:49:48 AM
#1037   ABBV reports 2Q15 results on 7/24/15 before the DewDiligence 07/02/15 10:20:36 AM
#1036   Both Abbvie AND Gilead have recently said that willyw 06/30/15 10:28:40 AM
#1035   Positive movement on V-Pak scripts: #msg-115042246. DewDiligence 06/30/15 09:51:14 AM
#1034   Hints that ABT-493/ABT-530 regimen is producing good results DewDiligence 06/30/15 09:48:24 AM
#1033   ENTA hires CMO: DewDiligence 06/30/15 09:45:49 AM
PostSubject